Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

QTRX

Quanterix (QTRX)

Quanterix Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:QTRX
DateHeureSourceTitreSymboleSociété
31/05/202422h01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:QTRXQuanterix Corporation
22/05/202422h00Business WireQuanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024NASDAQ:QTRXQuanterix Corporation
16/05/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
08/05/202420h55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTRXQuanterix Corporation
07/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
07/05/202422h00Business WireQuanterix Releases Financial Results for the First Quarter of 2024NASDAQ:QTRXQuanterix Corporation
29/04/202422h00Business WireQuanterix To Report First Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
21/03/202422h30Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing InfrastructureNASDAQ:QTRXQuanterix Corporation
04/03/202423h27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTRXQuanterix Corporation
04/03/202415h00Business WireQuanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
29/02/202422h58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QTRXQuanterix Corporation
29/02/202422h00Business WireQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023NASDAQ:QTRXQuanterix Corporation
27/02/202400h58Business WireQuanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceNASDAQ:QTRXQuanterix Corporation
26/02/202415h00Business WireQuanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
23/02/202422h30Business WireQuanterix to Present at Cowen’s 44th Annual Health Care ConferenceNASDAQ:QTRXQuanterix Corporation
16/02/202422h00Business WireQuanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallNASDAQ:QTRXQuanterix Corporation
14/02/202422h57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
02/01/202423h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QTRXQuanterix Corporation
12/12/202322h00Business WireQuanterix to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
13/11/202322h00Business WireQuanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:QTRXQuanterix Corporation
13/11/202313h00GlobeNewswire Inc.Sotera Health Appoints Karen Flynn to Board of DirectorsNASDAQ:QTRXQuanterix Corporation
06/11/202323h56Business WireQuanterix Releases Operating Results for Third Quarter 2023NASDAQ:QTRXQuanterix Corporation
06/11/202322h50Business WireQuanterix Releases Operating Results for Third Quarter 202NASDAQ:QTRXQuanterix Corporation
30/10/202321h00Business WireQuanterix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:QTRXQuanterix Corporation
24/10/202322h30Business WireQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
24/10/202302h30Business WireQuanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease DetectionNASDAQ:QTRXQuanterix Corporation
28/09/202323h00Business WireQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease DayNASDAQ:QTRXQuanterix Corporation
05/09/202314h00Business WireQuanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
22/08/202323h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
21/08/202322h30Business WireWilliam P. Donnelly Appointed to Quanterix’s Board of DirectorsNASDAQ:QTRXQuanterix Corporation
 Showing the most relevant articles for your search:NASDAQ:QTRX